Correlation Between MRS (Magnetic Resonance Spectroscopy) and Tumor Response to Radiation Therapy in Breast Cancer

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01428739

Enrollment

Registered

2011-09-05

Start date

2007-12-31

Completion date

2014-09-30

Last updated

2017-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

cancer, MRS, Treatment response

Brief summary

Correlation between MRS and Tumor Response Therapy in Breast Cancer.

Detailed description

Correlation between MRS (Magnetic Resonance Spectroscopy and Tumor Response to Radiation in Breast Cancer

Interventions

DEVICEMRS

Procedure

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histologically confirmed diagnosed Breast cancer * Patient is 18 years or older * Karnofsky performance score \> 70 * No previously irradiated or recurrent breast cancer * No contraindication to MRS/MRI * Signed informed consent.

Design outcomes

Primary

Measure	Time frame	Description
MRS Correlation with Treatment Response	Up to One Year	measuring choline, water and fat levels by proton magnetic resonance spectroscopy in breast tumors in response to treatment

Secondary

Measure	Time frame
Correlation with Tumor Stage	Up to One year

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026